Claim
The study’s promoter results span HEK293 and Jurkat cell-line profiling, selected-promoter testing in primary human CD8-positive T cells, in-vitro NR4A2-subset characterization, and tumor-infiltrating engineered T cells in a melanoma xenograft model; these are experimental-system findings rather than clinical human evidence.
40 words; atomic claims are usually under 25a conjunction joins clauses that may be separately evaluablea comma-separated series may list several propositionsTopics
Not filed under any topic yet.
Assessment
Supported
Main unresolved issue: 1 counted evidence item has no independence review; repeats of one origin may be counted as several coverage:63d658bd-f7d8-8228-bb5c-4a2c4c76c1ad
Not yet independently audited.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.
Why?
Strongest counted support: The primary text directly reports the stated cell-line profiling and selected-promoter experiments in primary CD8-positive T cells, in vitro, and melanoma xenograft tumor-infiltrating engineered T cells. weight 1.800000 evidence
Review gaps: qualifiers reviewed, opposing search done, independence reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Unresolved.
Your view
Registered views
Nobody has registered a view yet.
Evidence for
-
From A modular synthetic promoter toolkit for programmable gene control in activated and chronically stimulated T cells Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Directly supports the experimental-system scope.
Evidence against
None.
Qualifications
None.
Suppressed as dependent
None.
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
| From | Relationship | To |
|---|---|---|
| 4c76c1ad | NARROWS | b249122a |
Review checklist
Review checks: 1 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | yes | 28674885 |
Summary
Supported. The main support is: The primary text directly reports the stated cell-line profiling and selected-promoter experiments in primary CD8-positive T cells, in vitro, and melanoma xenograft tumor-infiltrating engineered T cells. dca3a32d
A search for evidence in the opposing direction found something; see the counted evidence. fd3caa55
Review checks: 1 of 4. coverage:63d658bd-f7d8-8228-bb5c-4a2c4c76c1ad
Contribution history
| seq | event | detail |
|---|---|---|
| 25626 | APPENDED | |
| 25627 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 25636 | TASK_RESULT | by 1efd24fe (accepted) |